These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24065278)

  • 1. Template-constrained cyclic sulfopeptide HIV-1 entry inhibitors.
    Rudick JG; Laakso MM; Schloss AC; DeGrado WF
    Org Biomol Chem; 2013 Nov; 11(41):7096-100. PubMed ID: 24065278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. I: 2(S)-methyl piperazine as a key pharmacophore element.
    Tagat JR; McCombie SW; Steensma RW; Lin S; Nazareno DV; Baroudy B; Vantuno N; Xu S; Liu J
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2143-6. PubMed ID: 11514156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mononucleoside phosphorodithiolates as mononucleotide prodrugs.
    Schlienger N; Lefebvre I; Aubertin AM; Peyrottes S; Périgaud C
    Eur J Med Chem; 2022 Jan; 227():113914. PubMed ID: 34695774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 antagonists: bicyclic isoxazolidines as conformationally constrained N-1-substituted pyrrolidines.
    Lynch CL; Gentry AL; Hale JJ; Mills SG; MacCoss M; Malkowitz L; Springer MS; Gould SL; DeMartino JA; Siciliano SJ; Cascieri MA; Doss G; Carella A; Carver G; Holmes K; Schleif WA; Danzeisen R; Hazuda D; Kessler J; Lineberger J; Miller M; Emini EA
    Bioorg Med Chem Lett; 2002 Feb; 12(4):677-9. PubMed ID: 11844699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV co-receptor CCR5: structure and interactions with inhibitors.
    Wang T; Duan Y
    Infect Disord Drug Targets; 2009 Jun; 9(3):279-88. PubMed ID: 19519482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of HIV-1 entry inhibitors based on broadly neutralizing antibody 447-52D and gp120 V3loop interactions.
    Senapathi J; Bommakanti A; Vangara S; Kondapi AK
    Bioorg Chem; 2021 Nov; 116():105313. PubMed ID: 34517280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.
    Pollicita M; Ruff MR; Pert CB; Polianova MT; Schols D; Ranazzi A; Perno CF; Aquaro S
    Antivir Chem Chemother; 2007; 18(5):285-95. PubMed ID: 18046961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic Envelope Glycoprotein Antagonists that Irreversibly Inactivate HIV-1 before Host Cell Encounter.
    Rashad AA; Kalyana Sundaram RV; Aneja R; Duffy C; Chaiken I
    J Med Chem; 2015 Sep; 58(18):7603-8. PubMed ID: 26331669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization.
    Arnatt CK; Falls BA; Yuan Y; Raborg TJ; Masvekar RR; El-Hage N; Selley DE; Nicola AV; Knapp PE; Hauser KF; Zhang Y
    Bioorg Med Chem; 2016 Nov; 24(22):5969-5987. PubMed ID: 27720326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved guanide compounds which bind the CXCR4 co-receptor and inhibit HIV-1 infection.
    Wilkinson RA; Pincus SH; Song K; Shepard JB; Weaver AJ; Labib ME; Teintze M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2197-201. PubMed ID: 23434419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s.
    Nakata H; Maeda K; Das D; Chang SB; Matsuda K; Rao KV; Harada S; Yoshimura K; Ghosh AK; Mitsuya H
    Sci Rep; 2019 Mar; 9(1):4828. PubMed ID: 30886166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV co-receptors as targets for antiviral therapy.
    Schols D
    Curr Top Med Chem; 2004; 4(9):883-93. PubMed ID: 15134547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction.
    Tavassoli A; Lu Q; Gam J; Pan H; Benkovic SJ; Cohen SN
    ACS Chem Biol; 2008 Dec; 3(12):757-64. PubMed ID: 19053244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfotyrosine dipeptide: Synthesis and evaluation as HIV-entry inhibitor.
    Ju T; Hu D; Xiang SH; Guo J
    Bioorg Chem; 2016 Oct; 68():105-11. PubMed ID: 27475281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential use of CCR5 by HIV-1 clinical isolates resistant to small-molecule CCR5 antagonists.
    Henrich TJ; Lewine NR; Lee SH; Rao SS; Berro R; Gulick RM; Moore JP; Tsibris AM; Kuritzkes DR
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1931-5. PubMed ID: 22252820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity analysis of diphenylpyrazolodiazene inhibitors of the HIV-1 Nef virulence factor.
    Iyer PC; Zhao J; Emert-Sedlak LA; Moore KK; Smithgall TE; Day BW
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1702-6. PubMed ID: 24650642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and SAR of heterocycle-containing antagonists of the human CCR5 receptor for the treatment of HIV-1 infection.
    Kim D; Wang L; Caldwell CG; Chen P; Finke PE; Oates B; MacCoss M; Mills SG; Malkowitz L; Gould SL; DeMartino JA; Springer MS; Hazuda D; Miller M; Kessler J; Danzeisen R; Carver G; Carella A; Holmes K; Lineberger J; Schleif WA; Emini EA
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3103-6. PubMed ID: 11720852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise of CCR5 antagonists as new therapies for HIV-1.
    Repik A; Richards KH; Clapham PR
    Curr Opin Investig Drugs; 2007 Feb; 8(2):130-9. PubMed ID: 17328229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailable, potent CCR5 antagonist.
    Tagat JR; Steensma RW; McCombie SW; Nazareno DV; Lin SI; Neustadt BR; Cox K; Xu S; Wojcik L; Murray MG; Vantuno N; Baroudy BM; Strizki JM
    J Med Chem; 2001 Oct; 44(21):3343-6. PubMed ID: 11585438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing Mercaptobenzamides as HIV Inactivators via Nucleocapsid Protein 7.
    Saha M; Scerba MT; Shank NI; Hartman TL; Buchholz CA; Buckheit RW; Durell SR; Appella DH
    ChemMedChem; 2017 May; 12(10):714-721. PubMed ID: 28395128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.